+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Exoskeleton Market by Component, Type, Technology, Functionality, Structure, Mode of Operation, Application, End-Use - Global Forecast to 2030- Product Image
Medical Exoskeleton Market by Component, Type, Technology, Functionality, Structure, Mode of Operation, Application, End-Use - Global Forecast to 2030- Product Image
Sale

Medical Exoskeleton Market by Component, Type, Technology, Functionality, Structure, Mode of Operation, Application, End-Use - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533178
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Exoskeleton Market grew from USD 1.66 billion in 2024 to USD 1.87 billion in 2025. It is expected to continue growing at a CAGR of 12.78%, reaching USD 3.42 billion by 2030.

Introduction to the Global Medical Exoskeleton Evolution

Medical exoskeletons are reshaping patient care, rehabilitation and mobility assistance by integrating robotics with human biomechanics. Fueled by an aging population, rising incidence of neurological disorders and a growing demand for assistive technologies, this category has moved from niche clinical prototypes to commercially viable systems. Vested stakeholders-including healthcare providers, device manufacturers and defense agencies-are collaborating to advance actuator designs, sensor arrays and control algorithms that enhance wearer comfort and safety. Simultaneously, software platforms for real-time monitoring and adaptive feedback are gaining prominence, forging a new era of personalized, data-driven care. As regulatory pathways streamline and reimbursement frameworks emerge, market participants must navigate a complex ecosystem of clinical validation, supply chain management and cross-sector partnerships. This introduction sets the stage for an in-depth exploration of the forces redefining the global medical exoskeleton landscape, guiding decision-makers through the technological, regulatory and commercial dynamics that will determine the next wave of innovation and adoption.

Transformative Shifts Reshaping the Medical Exoskeleton Landscape

The medical exoskeleton sector is undergoing a profound transformation driven by advances in mechatronics and artificial intelligence. Rapid improvements in actuator efficiency and miniaturization are enabling lighter, more ergonomic hardware. Innovations in sensor fusion and machine-learning algorithms now allow exoskeletons to anticipate movement patterns and adjust assistance in real time. A shift from rigid frameworks toward soft, textile-based structures is enhancing wearer comfort and expanding applications beyond rehabilitation clinics into homecare and sports performance. Concurrently, integration of cloud-based monitoring software is empowering clinicians with remote diagnostics and outcome tracking, facilitating tele-rehabilitation models. Regulatory bodies in North America and Europe are accelerating approval processes by adopting harmonized safety standards, while reimbursement policies increasingly reflect the long-term cost savings of reduced hospitalization and improved patient independence. These converging forces are enabling a transition from purely therapeutic devices to multifunctional platforms capable of diagnostic support, surgical assistance and therapeutic interventions, thus redefining the role of exoskeletons across the continuum of care.

Assessing the 2025 United States Tariffs on Exoskeleton Components

The imposition of new tariffs on imported exoskeleton components in 2025 has created both challenges and strategic opportunities. Increased duties on actuators, microcontrollers and precision sensors have elevated production costs, prompting manufacturers to reassess supply chain configurations. In response, several leading companies have announced plans to localize assembly operations and forge partnerships with domestic electronics producers. As a result, procurement cycles in rehabilitation centers and elderly care facilities are experiencing longer lead times and price adjustments. Conversely, tariff-driven incentives are stimulating investment in local manufacturing ecosystems, triggering government grants and public-private collaborations focused on industrial robotics. On the software side, import restrictions have minimal impact, allowing control and monitoring platforms to remain agile and scalable. Looking ahead, the sector is likely to balance short-term cost pressures with long-term gains from regionalized production, improved supply resilience and enhanced regulatory alignment for critical medical devices.

Insightful Analysis of Market Segmentation Dimensions

An in-depth look at market segmentation reveals distinct dynamics across multiple dimensions. Based on component breakdown, hardware-including actuators, microcontrollers and sensors-drives capital expenditure, while control and monitoring software platforms generate recurring revenue through updates and service fees. When viewed by type, passive exoskeletons leverage mechanical support to reduce caregiver burden, whereas powered systems actively amplify user mobility and strength. Technology segmentation highlights four core approaches-electric, hydraulic, mechanical and pneumatic-each offering trade-offs between power density, responsiveness and maintenance requirements. Functionality ranges from full-body systems that support comprehensive gait training to focused upper and lower body devices targeting limb-specific rehabilitation. Structural considerations differentiate rigid exoskeleton frames from emerging soft exosuits that conform to the wearer’s anatomy. Modes of operation span fully autonomous exoskeletons with embedded intelligence, manually controlled devices relying on user input and semi-autonomous hybrids that blend both paradigms. Application segmentation extends from assistive mobility solutions and diagnostic support through post-operative rehabilitation, surgical assistance and therapeutic uses such as orthopedic recovery and physical therapy. Finally, end-use environments encompass elderly care facilities, homecare settings, military and defense operations, research institutions and sports and fitness centers, each presenting unique performance and compliance requirements.

Regional Dynamics Influencing Medical Exoskeleton Adoption

Regional adoption patterns reflect a blend of demographic needs, policy frameworks and industrial capabilities. In the Americas, robust healthcare infrastructure and well-established reimbursement models are accelerating deployment in stroke rehabilitation centers and veteran care programs. Research consortia and defense agencies are also investing heavily in exoskeleton R&D, driving collaboration between academia and industry. In Europe, the Middle East and Africa, growing emphasis on reducing hospital stays and addressing workforce shortages in eldercare is fueling interest in assistive devices, while defense contracts in the Gulf region support high-performance exosuits. The Asia-Pacific region presents one of the fastest-growing markets, buoyed by an expanding middle-class consumer base, increased healthcare expenditure and government initiatives aimed at fostering robotics innovation. Local manufacturers are rapidly scaling production, often through joint ventures with global technology providers, to meet rising demand in clinical, homecare and sports rehabilitation applications. Navigating these regional nuances is essential for stakeholders aiming to optimize market entry and expansion strategies.

Profiling Leading Innovators and Market Players

The competitive landscape features a mix of specialized robotics firms, established medical device companies and technology conglomerates. Leading innovators such as Ekso Bionics and ReWalk Robotics continue to refine gait-training platforms, while Ottobock focuses on modular, clinically validated solutions. Parker Hannifin has leveraged its expertise in fluid power systems to introduce pneumatic exoskeletons tailored for industrial rehabilitation. Cyberdyne’s HAL system distinguishes itself through direct neural interfaces, enabling intuitive motion control. Meanwhile, newcomer startups are entering the field with soft exosuit designs that prioritize wearability and cost-efficiency. Strategic partnerships and acquisitions are reshaping market dynamics: partnerships between exoskeleton developers and telehealth providers are emerging, and medical device giants are acquiring niche robotics firms to broaden their portfolios. This convergence of specialist expertise and scale-driven players is driving rapid iteration in both hardware refinement and software intelligence, raising the bar for performance and integration.

Strategic Recommendations for Industry Leaders

To capitalize on evolving market opportunities, industry leaders should prioritize several strategic initiatives. First, investing in localized manufacturing and assembly can mitigate tariff impacts and shorten delivery timelines. Second, accelerating software development-particularly in AI-driven adaptive control and remote monitoring-will enhance device personalization and create new service revenue streams. Third, exploring soft exosuit technologies can expand application reach into homecare and sports, where comfort and aesthetics are paramount. Fourth, engaging early with regulatory bodies to secure streamlined approvals and favorable reimbursement codes will reduce commercial entry barriers. Fifth, forming cross-sector alliances with academic institutions, rehabilitation centers and defense agencies can fast-track clinical validation and broaden use cases. Finally, integrating robust data analytics and outcome measurement frameworks will support evidence-based marketing, strengthen payer negotiations and underscore long-term value for patients and providers.

Robust Research Methodology and Data Synthesis Approach

This study combines rigorous secondary research with targeted primary inquiries to deliver an accurate, multi-dimensional view of the medical exoskeleton market. Secondary sources include peer-reviewed journals, patent databases, regulatory filings and company disclosures. Primary research involved in-depth interviews with clinical specialists, procurement managers, technology providers and end-user representatives to validate market drivers, adoption barriers and growth enablers. Data triangulation techniques were applied to reconcile discrepancies and ensure robustness across qualitative and quantitative findings. A structured segmentation framework underpins the analysis, dissecting market dynamics by component, type, technology, functionality, structure, mode of operation, application and end-use. Regional insights draw upon country-level policy reviews and leading indicators of healthcare investment. Competitive assessments leverage benchmarking against product specifications, strategic alliances and financial performance. Throughout, meticulous data validation and peer review were conducted to uphold the highest standards of accuracy and reliability.

Concluding Perspectives on Medical Exoskeleton Trajectories

In summary, the medical exoskeleton market stands at an inflection point where technological breakthroughs, demographic imperatives and policy drivers converge. While 2025 tariffs have introduced short-term cost pressures, they have also catalyzed supply chain resilience and domestic manufacturing initiatives. Detailed segmentation analysis highlights diverse needs across hardware, software, application and end-use categories, underscoring the importance of tailored product strategies. Regional dynamics vary markedly, with the Americas leading in clinical adoption, EMEA focusing on eldercare and defense, and Asia-Pacific accelerating through domestic collaborations. Key players are differentiating via advanced actuators, neural interfaces and integrated software platforms. To sustain momentum, industry stakeholders must adopt agile manufacturing, deepen software capabilities and forge strategic partnerships. This comprehensive assessment offers a roadmap for navigating competitive challenges and capturing emerging opportunities in the evolving landscape of medical exoskeletons.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Component
    • Hardware
      • Actuators
      • Microcontrollers
      • Sensors
    • Software
      • Control Software
      • Monitoring Software
  • Type
    • Passive Exoskeletons
    • Powered Exoskeletons
  • Technology
    • Electric
    • Hydraulic
    • Mechanical
    • Pneumatic
  • Functionality
    • Full Body Exoskeletons
    • Lower Body Exoskeletons
    • Upper Body Exoskeletons
  • Structure
    • Rigid Exoskeletons
    • Soft Exoskeletons
  • Mode of Operation
    • Autonomous Exoskeletons
    • Manual Controlled
    • Semi Autonomous/Assisted
  • Application
    • Assistive Devices for Mobility
      • Disabled Patients
      • Elderly Assistance
    • Diagnostic Support
    • Rehabilitation
    • Surgical Assistance
    • Therapeutic Use
      • Orthopedic Recovery
      • Physical Therapy
  • End-Use
    • Elderly Care Facilities
    • Homecare Settings
    • Military & Defense
    • Research Institutions & Universities
    • Sports & Fitness
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • B-Temia Inc.
  • Comau S.p.A.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings Inc.
  • ExoAtlet, LLC
  • Focal Meditech BV
  • Honda Motor Co. Ltd.
  • Hyundai Motor Company
  • Levitate Technologies, Inc.
  • Lockheed Martin Corporation
  • Mitsubishi Heavy Industries, Ltd.
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • P&S Mechanics Co., Ltd.
  • Panasonic Holdings Corporation
  • Parker Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Rex Bionics Plc
  • Roam Robotics
  • Toyota Motor Corporation
  • Trexo Robotics, Inc.
  • Wandercraft S.A.S.
  • Yaskawa Electric Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Navigating the Medical Exoskeleton Frontier: Market Position, Evolution, and Growth Challenges
3.2. Decoding Consumer Drivers and Strategic Positioning in Exoskeleton Markets
3.3. Lifecycle, Intellectual Property, and Strategic Go-To-Market Blueprint
3.4. Forecasting Growth Phases, Strategic Options, and Emerging Trends in Exoskeletons
4. Market Overview
4.1. Introduction
4.1.1. Unleashing Potential: Defining the Medical Exoskeleton Market and Its Growth Catalysts
4.1.2. Regional Dynamics Shaping Exoskeleton Adoption Across Key Markets
4.1.3. Recent Innovations and Strategic Moves Driving Exoskeleton Commercialization
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms for adaptive exoskeleton assistance in rehabilitation programs
5.1.1. Decoding the Rise of AI-Driven Adaptive Exoskeleton Assistance
5.1.2. Strategic Imperatives for Companies in the AI-Enabled Exoskeleton Era
5.1.3. The Future Trajectory of AI-Integrated Exoskeletons in Rehabilitation
5.2. Adoption of lightweight composite materials and modular designs to enhance patient comfort and mobility in exoskeleton devices
5.2.1. Lightweight Composites and Modular Architecture Defined
5.2.2. Unlocking Market Opportunities through Comfort and Customization
5.2.3. Charting the Future of Composite Modular Exoskeletons
5.3. Strategic partnerships between medical exoskeleton startups and major healthcare providers for clinical trial expansion
5.3.1. Collaborative Clinical Trial Expansion in Medical Exoskeletons
5.3.2. Transforming Market Dynamics through Strategic Healthcare Alliances
5.3.3. Projecting the Path and Pitfalls of Exoskeleton Partnerships
5.4. Emergence of tele-rehabilitation platforms with remote monitoring capabilities in medical exoskeleton treatments
5.4.1. Understanding the Rise of Remote Tele-Rehabilitation in Exoskeleton Therapy
5.4.2. Strategic Shifts for Providers Embracing Remote Monitoring Platforms
5.4.3. Future Trajectory of Tele-Rehabilitation Integration in Exoskeleton Care
5.5. Advancements in battery technology and wireless control systems to extend exoskeleton operational duration in clinical settings
5.5.1. Driving Extended Use: Why Energy and Connectivity Matter
5.5.2. Strategic Shifts for Long-Lasting Devices
5.5.3. Future Trajectory of Endurance Enhancements
5.6. Regulatory approvals and updated reimbursement frameworks driving increased accessibility of medical exoskeleton therapies
5.6.1. Unlocking Access Through Evolving Approval and Reimbursement Policies
5.6.2. Emerging Pathways for Growth and Innovation in Exoskeleton Therapies
5.6.3. Navigating Future Challenges and Strategic Considerations in Exoskeleton Markets
5.7. Integration of virtual reality environments with exoskeleton systems for immersive neurorehabilitation and patient engagement
5.7.1. Unlocking Immersive Rehab: VR and Exoskeleton Convergence Explained
5.7.2. Adapting to Immersive Rehab: Strategic Shifts for Exoskeleton Providers
5.7.3. Navigating the Next Wave: Future of VR-Driven Exoskeleton Neurorehab
5.8. Customization of exoskeleton design through 3D scanning and additive manufacturing accelerating patient-specific fit
5.8.1. Precision-Fitted Exoskeletons Enabled by 3D Scanning and Printing
5.8.2. Adapting Business Models to Patient-Specific Exoskeletons
5.8.3. Anticipating the Next Phase of Custom Exoskeleton Innovation
5.9. Expansion of tele-rehabilitation platforms incorporating remote-controlled exoskeleton training for stroke patients
5.9.1. Tele-Rehab Platforms Revolutionizing Stroke Recovery with Remote Exoskeleton Control
5.9.2. Strategic Shifts Required to Leverage Tele-Exoskeleton Rehabilitation
5.9.3. Where Tele-Rehabilitation with Exoskeletons Is Headed in the Coming Years
5.10. Surge in soft robotic exosuit adoption for elderly mobility support in home healthcare settings
5.10.1. Drivers Behind the Rise of Soft Robotic Exosuits in Home Elderly Care
5.10.2. Strategic Shifts for Providers Embracing Soft Exosuits
5.10.3. Future Trajectory of Soft Exosuit Adoption in Home Healthcare
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. Formidable Gatekeepers: High Barriers to Entry in Medical Exoskeletons
6.1.2. Emerging Threats from Nontraditional Substitutes
6.1.3. Supplier Clout: Limited Sources and Specialized Components
6.1.4. Empowered Buyers Demand Cost and Performance Leverage
6.1.5. Intense Rivalry Fueled by Innovation and Strategic Alliances
6.2. PESTLE Analysis
6.2.1. Reimbursement and Regulatory Approvals Shape Exoskeleton Adoption
6.2.2. Healthcare Budget Growth Versus Cost Containment Pressures
6.2.3. Demographic Shifts Elevate Demand for Mobility Solutions
6.2.4. AI and Advanced Manufacturing Propel Exoskeleton Evolution
6.2.5. Evolving Medical Device Regulations Impact Market Entry
6.2.6. Sustainability Imperatives Reshape Exoskeleton Manufacturing
7. Cumulative Impact of United States Tariffs 2025
7.1. Tariff Surge 2023-2025: A Closer Look at Key US Import Levies
7.2. From Protectionism to Resilience: The Evolutionary Rationale of US Tariff Policy
7.3. Tariffs as Inflation Catalysts: Quantifying the Direct Price Pressures
7.4. Escalating Reciprocity: Trade Wars and Geopolitical Flashpoints
7.5. Ripple Effects Abroad: Economic and Political Fallout in Key Partner Economies
7.6. From Shifting Factories to New Consumption Habits: Structural Transformations Induced by Tariffs
7.7. Charting a Path Forward: Policy Remedies to Soften Tariff Strains
8. Medical Exoskeleton Market, by Component
8.1. Introduction
8.2. Hardware
8.2.1. Actuators
8.2.2. Microcontrollers
8.2.3. Sensors
8.3. Software
8.3.1. Control Software
8.3.2. Monitoring Software
9. Medical Exoskeleton Market, by Type
9.1. Introduction
9.2. Passive Exoskeletons
9.3. Powered Exoskeletons
10. Medical Exoskeleton Market, by Technology
10.1. Introduction
10.2. Electric
10.3. Hydraulic
10.4. Mechanical
10.5. Pneumatic
11. Medical Exoskeleton Market, by Functionality
11.1. Introduction
11.2. Full Body Exoskeletons
11.3. Lower Body Exoskeletons
11.4. Upper Body Exoskeletons
12. Medical Exoskeleton Market, by Structure
12.1. Introduction
12.2. Rigid Exoskeletons
12.3. Soft Exoskeletons
13. Medical Exoskeleton Market, by Mode of Operation
13.1. Introduction
13.2. Autonomous Exoskeletons
13.3. Manual Controlled
13.4. Semi Autonomous/Assisted
14. Medical Exoskeleton Market, by Application
14.1. Introduction
14.2. Assistive Devices for Mobility
14.2.1. Disabled Patients
14.2.2. Elderly Assistance
14.3. Diagnostic Support
14.4. Rehabilitation
14.5. Surgical Assistance
14.6. Therapeutic Use
14.6.1. Orthopedic Recovery
14.6.2. Physical Therapy
15. Medical Exoskeleton Market, by End-Use
15.1. Introduction
15.2. Elderly Care Facilities
15.3. Homecare Settings
15.4. Military & Defense
15.5. Research Institutions & Universities
15.6. Sports & Fitness
16. Americas Medical Exoskeleton Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Medical Exoskeleton Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Medical Exoskeleton Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. B-Temia Inc.
19.3.1.1. Establishing a Emerging Footprint in Medical Exoskeletons
19.3.1.2. Flagship Exoskeleton Technology Driving Clinical Outcomes
19.3.1.3. Strengthening Resilience Through Diversification and Digital Innovation
19.3.2. Comau S.p.A.
19.3.2.1. Charting Comau’s Entry and Current Standing in Medical Exoskeletons
19.3.2.2. RehaX Exoskeleton: Adaptive Rehabilitation Meets Tele-Health
19.3.2.3. Mitigating Hurdles to Secure Sustainable Market Expansion
19.3.3. Cyberdyne Inc.
19.3.3.1. Pioneering the Market: From Launch to Leadership in Wearable Robotics
19.3.3.2. Inside HAL: Features and Value Driving Patient Mobility and Clinical Adoption
19.3.3.3. Overcoming Hurdles: Mitigating Risks and Fortifying Future Growth Strategies
19.3.4. Ekso Bionics Holdings Inc.
19.3.4.1. From Prototype to Global Leader: Charting Ekso Bionics’ Market Evolution
19.3.4.2. Adaptive Robotics in Action: Unpacking Ekso’s Flagship Offerings
19.3.4.3. Fortifying the Future: Addressing Risks and Strengthening Competitive Position
19.3.5. ExoAtlet, LLC
19.3.5.1. From Startup to Market Challenger: ExoAtlet’s Journey and Positioning
19.3.5.2. Signature Exoskeleton Solutions: Core Offerings and Differentiators
19.3.5.3. Navigating Risks and Fortifying ExoAtlet’s Competitive Edge
19.3.6. Focal Meditech BV
19.3.6.1. Forging a Footprint: Focal Meditech BV’s Market Entry and Positioning
19.3.6.2. Reinventing Rehabilitation: Deep Dive into Focal Meditech’s Exoskeleton Portfolio
19.3.6.3. Navigating Risks and Charting Strategic Paths for Sustainable Growth
19.3.7. Honda Motor Co. Ltd.
19.3.7.1. Forging a Leadership Stance in Medical Exoskeletons
19.3.7.2. Pioneering Wearable Support with Stride Management Assist
19.3.7.3. Navigating Risks and Crafting Strategic Growth Pathways
19.3.8. Hyundai Motor Company
19.3.8.1. From Automotive Roots to Walking Aids: Hyundai’s Medical Exoskeleton Journey
19.3.8.2. Inside Hyundai’s H-MEX: A High-Tech Lifeline for Rehabilitation
19.3.8.3. Navigating Headwinds: Risks and Strategies for Hyundai’s Exoskeleton Future
19.3.9. Levitate Technologies, Inc.
19.3.9.1. Pioneering Industrial Wearable Robotics with Strategic Acumen
19.3.9.2. Aura Exosuit Series: Revolutionizing Workforce Mobility
19.3.9.3. Mitigating Growth Risks with Strategic Diversification and Innovation
19.3.10. Lockheed Martin Corporation
19.3.10.1. Forging Leadership Through Technology Integration and Global Reach
19.3.10.2. Showcasing Flagship Platforms That Define Market Leadership
19.3.10.3. Mitigating Strategic Risks While Unlocking Growth Pathways
19.3.11. Mitsubishi Heavy Industries, Ltd.
19.3.11.1. Charting Mitsubishi Heavy Industries’ Strategic Ascent in Medical Exoskeletons
19.3.11.2. Unpacking Flagship Exoskeleton Innovations That Reshape Patient Care
19.3.11.3. Mitigating Risks and Steering Growth Through Strategic Exoskeleton Evolution
19.3.12. Myomo, Inc.
19.3.12.1. From Academic Spin-Out to Upper-Limb Exoskeleton Leader
19.3.12.2. MyoPro Powered Orthosis Transforming Upper-Limb Rehabilitation
19.3.12.3. Navigating Risks and Fortifying Market Resilience
19.3.13. Ottobock SE & Co. KGaA
19.3.13.1. From Prosthetic Pioneer to Exoskeleton Leader
19.3.13.2. Empowering Mobility Through Innovative Exoskeleton Solutions
19.3.13.3. Navigating Challenges to Sustain Growth and Resilience
19.3.14. P&S Mechanics Co., Ltd.
19.3.14.1. Building a Leadership Position Through Clinical Partnerships and Product Milestones
19.3.14.2. Flagship Exoskeletons Delivering Superior Clinical Outcomes and User Experience
19.3.14.3. Mitigating Risks with Portfolio Diversification and Service-Driven Models
19.3.15. Panasonic Holdings Corporation
19.3.15.1. From Robotics Roots to Rehab Innovation: Panasonic’s Exoskeleton Journey
19.3.15.2. RehaAssist X1 Unveiled: Panasonic’s Flagship in Wearable Rehabilitation
19.3.15.3. Navigating Hurdles Ahead: Mitigating Risks in Panasonic’s Exoskeleton Venture
19.3.16. Parker Hannifin Corporation
19.3.16.1. Forging a Global Foothold in Precision Motion Control
19.3.16.2. Elevating Rehabilitation with Advanced Exoskeleton Solutions
19.3.16.3. Mitigating Risks and Seizing Innovation Pathways
19.3.17. ReWalk Robotics Ltd.
19.3.17.1. Forging Ground for Mobility: ReWalk’s Strategic Footprint in Exoskeleton Therapy
19.3.17.2. Elevating Lives: In-Depth Look at ReWalk’s Signature Exoskeleton Solutions
19.3.17.3. Navigating Headwinds: Risks and Strategic Pathways for ReWalk’s Next Chapter
19.3.18. Rex Bionics Plc
19.3.18.1. From Startup to Niche Innovator: Rex Bionics’ Journey and Market Positioning
19.3.18.2. Rex Exoskeleton Unveiled: Features and Differentiators Driving Mobility
19.3.18.3. Overcoming Hurdles: Mitigating Risks and Strengthening Rex’s Road Ahead
19.3.19. Roam Robotics
19.3.19.1. Pioneering Mobility: Roam Robotics' Market Footprint
19.3.19.2. Elevating Performance: In-Depth Look at Roam Robotics’ Flagship Exoskeletons
19.3.19.3. Navigating Uncertainty: Risks and Strategic Growth Pathways
19.3.20. Toyota Motor Corporation
19.3.20.1. Global Automotive Leader Forged Through Innovation and Scale
19.3.20.2. Flagship Mobility Solutions Driving Consumer Loyalty
19.3.20.3. Navigating Risks with Strategic Agility and Diversification
19.3.21. Trexo Robotics, Inc.
19.3.21.1. Trailblazing Pediatric Mobility: Trexo’s Market Entry and Positioning
19.3.21.2. Inside Trexo’s Robotic Gait Solutions: Features, Functions, and USPs
19.3.21.3. Guarding Future Growth: Risks, Weaknesses, and Strategic Imperatives
19.3.22. Wandercraft S.A.S.
19.3.22.1. From Lab Prototype to Niche Leader in Autonomous Exoskeletons
19.3.22.2. Balancing Innovation and Independence with Atalante Exoskeletons
19.3.22.3. Strengthening Resilience Amid Cost, Regulatory, and Competitive Challenges
19.3.23. Yaskawa Electric Corporation
19.3.23.1. Yaskawa’s Strategic Robotics Legacy Fuels Its Medical Exoskeleton Leadership
19.3.23.2. Medical Assist Exoskeletons That Redefine Patient-Centric Rehabilitation
19.3.23.3. Mitigating Risks and Accelerating Next-Generation Exoskeleton Innovation
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. MEDICAL EXOSKELETON MARKET MULTI-CURRENCY
FIGURE 2. MEDICAL EXOSKELETON MARKET MULTI-LANGUAGE
FIGURE 3. MEDICAL EXOSKELETON MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. MEDICAL EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. MEDICAL EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MEDICAL EXOSKELETON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MICROCONTROLLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY CONTROL SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PASSIVE EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY POWERED EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELECTRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RIGID EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFT EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY AUTONOMOUS EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MANUAL CONTROLLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SEMI AUTONOMOUS/ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY DISABLED PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELDERLY ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY DIAGNOSTIC SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ORTHOPEDIC RECOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELDERLY CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTIONS & UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SPORTS & FITNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 80. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 81. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 82. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 85. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 86. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 89. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 90. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 92. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 97. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 158. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 160. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 162. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 165. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 166. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 167. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 170. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 174. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 188. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 189. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 190. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 191. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 194. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 195. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 196. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 198. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 199. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 200. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 201. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 206. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 210. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 249. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 250. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 251. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 254. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 256. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 258. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 259. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 272. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 273. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 274. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 275. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 276. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 278. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 279. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 280. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 282. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 283. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 284. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 285. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 286. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 287. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 290. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 291. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 292. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 294. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 295. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 318. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 319. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 320. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 321. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 322. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 323. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 324. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 326. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 327. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 328. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 330. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 331. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 332. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 333. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 334. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 335. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 336. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 337. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 338. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
TABLE 339. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 340. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES FOR MOBILITY, 2018-2030 (USD MILLION)
TABLE 342. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY THERAPEUTIC USE, 2018-2030 (USD MILLION)
TABLE 343. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 344. ISRAEL MEDICAL EX

Companies Mentioned

The companies profiled in this Medical Exoskeleton market report include:
  • B-Temia Inc.
  • Comau S.p.A.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings Inc.
  • ExoAtlet, LLC
  • Focal Meditech BV
  • Honda Motor Co. Ltd.
  • Hyundai Motor Company
  • Levitate Technologies, Inc.
  • Lockheed Martin Corporation
  • Mitsubishi Heavy Industries, Ltd.
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • P&S Mechanics Co., Ltd.
  • Panasonic Holdings Corporation
  • Parker Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Rex Bionics Plc
  • Roam Robotics
  • Toyota Motor Corporation
  • Trexo Robotics, Inc.
  • Wandercraft S.A.S.
  • Yaskawa Electric Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.87 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.42 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Bionic Prosthetics & Exoskeletons Market by Device Type, Application - Global Forecast to 2030 - Product Image

Bionic Prosthetics & Exoskeletons Market by Device Type, Application - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Bionic Prosthetics & Mechanical Exoskeletons Market by Product Type, Technology, Material - Global Forecast to 2030 - Product Image

Bionic Prosthetics & Mechanical Exoskeletons Market by Product Type, Technology, Material - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users, and Key Geographical Regions - Product Image

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users, and Key Geographical Regions

  • Report
  • 224 Pages
  • Global
From
Medical Exoskeleton Market Report by Component, Type, Extremity, Mobility, End User, and Region 2024-2032 - Product Image

Medical Exoskeleton Market Report by Component, Type, Extremity, Mobility, End User, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Medical Exoskeleton - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Medical Exoskeleton - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From

About the Medical Exoskeleton Market

Medical Exoskeletons are a type of orthopedic device used to support and enhance the mobility of individuals with physical disabilities. They are designed to provide assistance to the user in performing everyday activities, such as walking, climbing stairs, and lifting objects. Exoskeletons are typically composed of a lightweight frame, motors, and sensors that are connected to the user's body. The frame is designed to provide support and stability to the user, while the motors and sensors provide feedback to the user to help them control their movements. Exoskeletons are becoming increasingly popular in the orthopedic device market due to their ability to improve the quality of life for individuals with physical disabilities. They can be used to help individuals with limited mobility to perform everyday tasks, as well as to improve their physical strength and endurance. Additionally, exoskeletons can be used to help individuals with spinal cord injuries to regain some of their lost mobility. Some of the companies in the medical exoskeleton market include Ekso Bionics, ReWalk Robotics, Bionik Laboratories, and Cyberdyne. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.